ScholarLens Back to search
2013•NeurologyRequires access

Use of Oral Aprepitant for the Management of Nausea with Inpatient Intravenous Dihydroergotamine (DHE) Use (S40.006)

Denise E. Chou, Peter James Goadsby

Open publisher page 0 citations

Abstract

OBJECTIVE: To assess the efficacy and tolerability of oral aprepitant in controlling nausea associated with intravenous dihydroergotamine administered for medically-refractory migraine.

About this research paper

What this paper is about

OBJECTIVE: To assess the efficacy and tolerability of oral aprepitant in controlling nausea associated with intravenous dihydroergotamine administered for medically-refractory migraine.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To assess the efficacy and tolerability of oral aprepitant in controlling nausea associated with intravenous dihydroergotamine administered for medically-refractory migraine.

Key concepts: Aprepitant, Nausea, Dihydroergotamine, Medicine, Vomiting, Antiemetic, Anesthesia, Migraine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Use of Oral Aprepitant for the Management of Nausea with Inpatient Intravenous Dihydroergotamine (DHE) Use (S40.006) — Research Paper | ScholarLens